Clinical Trials Study
Copyright ©The Author(s) 2023.
World J Hepatol. May 27, 2023; 15(5): 688-698
Published online May 27, 2023. doi: 10.4254/wjh.v15.i5.688
Table 1 Demographic and clinical data of the studied groups, n (%)
Group
Variables
GTMI (n = 21)
CG (n = 20)
Total/average (n = 41)
P value
Feminine gender7 (33.3)7 (35.0)14 (34.1)0.91042
Male gender14 (66.7)13 (65.0)27 (65.9)
Mean age (yr) (SD)56.7 ± 13.149.3 ± 16.153.1 ± 14.90.14011
Mean BMI (SD)28.3 ± 4.026.2 ± 6.227.3 ± 5.20.14041
Table 2 Diagnosis and background of the studied groups, n (%)
Group

Variables
GTMI (n = 21)
CG (n = 20)
Total (n = 41)
P value
Diagnostics
Liver metastasis9 (42.9)8 (40.0)17 (41.5)
Hepatocellular carcinoma8 (38.1)3 (15.0)11 (26.8)
Hepatic nodule3 (14.3)4 (20.0)7 (17.1)
Cholangiocarcinoma1 (4.8)4 (20.0)5 (12.2)
Hemangioma0 (0.0)1 (5.0)1 (2.4)-
Background
Hepatic cirrhosis
No15 (71.4)18 (90.0)33 (80.5)
Yes6 (28.6)2 (10.0)8 (19.5)0.23792
Hepatitis C
No17 (81.0)18 (90.0)35 (85.4)
Yes4 (19.0)2 (10.0)6 (14.6)0.66282
Previous neoplasm
No10 (47.6)8 (40.0)18 (43.9)
Yes11 (52.4)12 (60.0)23 (56.1)0.62321
Chemotherapy
No12 (57.1)13 (65.0)25 (61.0)
Yes9 (42.9)7 (35.0)16 (39.0)0.60621
Smoker/former smoker
No15 (71.4)18 (90.0)33 (80.5)
Yes6 (28.6)2 (10.0)8 (19.5)0.23792
Table 3 Complications and length of hospital stay in the postoperative period, n (%)
                                Group

Variables
GTMI (n = 21)
CG (n = 20)
Total (n = 41)
P value
Postoperative complications
No15 (71.4)13 (65.0)28 (68.3)
Yes6 (28.6)7 (35.0)13 (31.7)0.65842
Intraoperative bleeding (n)2 (9.5)0 (0.0)2 (4.9)
TEP0 (0.0)1 (5.0)1 (2.4)
Paralytic ileus2 (9.5)1 (5.0)3 (7.3)
Anemia1 (4.8)1 (5.0)2 (4.9)
PNM0 (0.0)1 (5.0)1 (2.4)
SPO2 drop < 920 (0.0)2 (10.0)2 (4.9)
ARI1 (4.8)0 (0.0)1 (2.4)
Biliary fistula0 (0.0)1 (5.0)1 (2.4)-
Postoperative hospital stay (in days)
Mean (SD)5.4 ± 2.07.1 ± 3.96.2 ± 3.20.05961
Table 4 Comparison of respiratory variables measured with the manovacuometer, ventilometer and with the Powerbreathe®between the preoperative, the first and fifth postoperative days of the inspiratory muscle training group and control group
GTMI (n = 21)
CG (n = 20)
P value2
Variables
Pre-op
PO first day1
PO fifth day
Pre-op
PO first day
PO fifth day
Manovacuometer
PIM (cmH2O)110.9 ± 4171.6 ± 42115.6 ± 51115.4 ± 7377.9 ± 5699.6 ± 680.0131
PEM (cmH2O)101.0 ± 2858.1 ± 2683.1 ± 30103.5 ± 4363.0 ± 3784.8 ± 420.6186
Ventilometer
CV (liters/min)2789 ± 9381423 ± 5891937 ± 5852705 ± 8361356 ± 3921737 ± 5410.6014
VT (mL)483.2 ± 273425.2 ± 183543.7 ± 221473.1 ± 213354.9 ± 161474.2 ± 1620.2866
VM (liters/min)6905 ± 34497060 ± 275311012 ± 53817732 ± 38496573 ± 27469117 ± 33250.2091
Powerbreathe®
Energy (joules)1.24 ± 1.40.61 ± 1.20.57 ± 0.30.87 ± 0.20.30 ± 0.10.52 ± 0.20.3098
Flow (liters/min)1.78 ± 1.00.86 ± 0.81.21 ± 0.51.52 ± 0.70.64 ± 0.30.93 ± 0.40.4224
Power (watts)0.99 ± 1.20.53 ± 1.00.53 ± 0.20.67 ± 0.30.32 ± 0.20.42 ± 0.20.3533
Pressure (cmH2O)4.86 ± 2.04.53 ± 1.74.31 ± 0.24.32 ± 0.24.11 ± 0.14.31 ± 0.50.1405
Volume (liters)1.82 ± 0.80.84 ± 0.51.15 ± 0.41.75 ± 0.50.61 ± 0.20.85 ± 0.20.0583